investiment.io
Mangoceuticals, Inc.
$2.48
0.04 (1.64%)
Mangoceuticals, Inc.
$2.48
0.04 (1.64%)
MGRX Price Chart
| Basic | |
|---|---|
| Market Cap | $4.95M |
| Price | $2.48 |
| 52 Week Range | 2.1-16.8 |
| Beta | 0.00 |
| Margins | |
| Gross Profit Margin | 58.60% |
| Operating Profit Margin | -1173.83% |
| Net Profit Margin | -1235.27% |
| Valuation (TTM) | |
| P/E Ratio | -0.54 |
| Price to Sales Ratio | 6.55 |
| Price to Book Ratio | 0.37 |
| PEG Ratio | 0.00 |
Industry
Medical - Healthcare Information Services
Sector
Healthcare
Full-Time Employees
3
Website
IPO Date
2023-03-21T00:00:00.000Z
Description
Mangoceuticals, Inc. focuses on develops, markets, and sells various men's wellness products and services through a telemedicine platform. It offers erectile dysfunction products under the Mango brand name. The company sells its products through online website mangorx.com. Mangoceuticals, Inc. was incorporated in 2021 and is headquartered in Dallas, Texas. Mangoceuticals, Inc. operates as a subsidiary of Cohen Enterprises, Inc.
Phone
(214) 242-9619
Address
15110 North Dallas Parkway, Dallas, TX, 75248, US
CIK
0001938046